Breaking News Bar

Business News and Information

Cambridge biotech Idera jumps into Duchenne muscular dystrophy field

Idera Pharmaceuticals is planning to develop a drug to treat boys with Duchenne muscular dystrophy that could be used with in conjunction others likely to be approved next year and that could work in boys with any underlying genetic mutations...
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
bottom clear